510(k) Report

FDA product code · Cardiovascular

Echocardiograph

DXKClass II21 CFR 870.2330510(k) required78 decisions since 19770 recalls

78 FDA decisions since 1977. No recall names this code. The most-cited predicate is K031148, named by 6 later devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, cardiovascular panel

Twenty years of DXK at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · DXK

1in 2018

2016: 12018: 1
2007high 1 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DXK

Too few DXK 510(k)s in any year since 2007 to give a median.

Recalls per year · DXK

No recall names DXK since 2007.

Adverse event reports per year · DXK

1in 2024

2012: 12017: 32018: 42019: 12020: 22021: 12024: 1
2007high 4 (2018) · low 0 (2007)2025

MAUDE reports naming product code DXK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—01
20130—00
20140—00
20150—00
20161—00
20170—03
20181—04
20190—01
20200—02
20210—01
20220—00
20230—00
20240—01
20250—00
20260—0—
FIG. 1 — DXK by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in DXK? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report